Top Markets
Coin of the day
Abbott Laboratories Abbott Laboratories

Abbott Laboratories

ABT
Kedudukan dalam Saham #118
Abbott Laboratories, along with its affiliated entities, is a global healthcare... Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
Harga Saham
$97.46
Disegerakkan terakhir: 2026-10-02
Modal Pasaran
$168.63B
Perubahan (1 hari)
0.77%
Perubahan (1 tahun)
-27.59%
Negara
US
Perdagangan Abbott Laboratories (ABT)

Kategori

Bilangan saham terbitan bagi Abbott Laboratories (ABT)
Bilangan saham terbitan setakat June 2026: 1.74B
Menurut laporan kewangan terkini dan harga saham Abbott Laboratories, bilangan saham terbitan semasa ialah 1.74B. Pada akhir December 2024, syarikat mempunyai 1.73B saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Abbott Laboratories (ABT) dari 2000 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
2026 (TTM) 1.74B -0.23%
2025 1.75B 0.88%
2024 1.73B -0.14%
2023 1.73B -1.08%
2022 1.75B -1.24%
2021 1.78B 0.11%
2020 1.77B 0.28%
2019 1.77B 0.71%
2018 1.76B 0.69%
2017 1.74B 18.38%
2016 1.47B 0.01%
2015 1.47B -2.35%
2014 1.51B -2.59%
2013 1.55B -1.81%
2012 1.58B 0.40%
2011 1.57B 1.51%
2010 1.55B 0.03%
2009 1.55B 0.19%
2008 1.54B 0.03%
2007 1.54B 0.87%
2006 1.53B -1.46%
2005 1.55B -0.52%
2004 1.56B -0.14%
2003 1.56B 0.12%
2002 1.56B 0.68%
2001 1.55B 0.15%
2000 1.55B 0.00%
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
1.28B -26.45%
IE
383.50M -78.00%
US
1.48B -15.23%
US
- -
DE
576.40M -66.93%
US